Global Acute Respiratory Distress Syndrome (ARDS) Market - Industry Trends and Forecast to 2029

Segmentation

Short Description
Global acute respiratory distress syndrome (ARDS) market, By Cause (Coronavirus Disease 2019 (COVID-19), Sepsis, Inhalation of Harmful Substances, Severe Pneumonia and Others), Type (Diagnosis and Treatment), Route of Administration (Parenteral Oral and Others), End User (Hospitals, Specialty Clinics, Home Healthcare and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Turkey, Hungary, Netherlands, Switzerland, Austria, Lithuania, Poland, Russia, Ireland, Norway, Rest of Europe, Japan , China, South Korea ,India Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of  Asia-Pacific, South Africa, Saudi Arabia, UAE, Israel, Egypt, Kuwait, Rest of Middle East and Africa, Brazil , Argentina, Peru, Rest of South America) Industry Trends and Forecast to 2029

Market Definition:
Acute respiratory distress syndrome (ARDS) is a life-threatening lung injury that allows fluid to leak into the lungs. Most people who get ARDS are already at the hospital for trauma or illness like COVID-19. The syndrome usually occurs when fluids build up in the tiny, elastic air sacs called alveoli in lungs. This fluid build-up causes less oxygen reach the bloodstream. This deprives the organs to get enough oxygen for their normal function. People with other illness develops ARDS within few hours to days after the precipitating injury or infection. The risk of death increases with age and depending on severity of illness patients surviving the syndrome becomes hard.  Severe illness or injury which causing damage to the membrane sacs of lungs leads to ARDS. The most common underlying causes for the said diseases includes sepsis, inhalation of harmful substances, severe pneumonia, head, chest or other major injury, coronavirus disease 2019 (COVID-19)  and others.

Market Segmentation:
Global acute respiratory distress syndrome (ARDS) market is categorized into five notable segments such as cause, type, route of administration, end users and distribution channel.

 On the basis of cause, the global acute respiratory distress syndrome (ARDS) market is segmented into coronavirus disease 2019 (COVID-19), sepsis, inhalation of harmful substances, severe pneumonia and others
 On the basis of type, the global acute respiratory distress syndrome (ARDS) market is segmented into diagnosis and treatment
 On the basis of route of administration, the global acute respiratory distress syndrome (ARDS) market is segmented into oral, parenteral and others
 On the basis of end-users, the global acute respiratory distress syndrome (ARDS) market is segmented into hospitals, specialty clinics, home healthcare and others
 On the basis of distribution channel, the global acute respiratory distress syndrome (ARDS) market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others


 Market Players

The key market players for global acute respiratory distress syndrome (ARDS) market are listed below:

 Drgerwerk AG & Co. KGaA
 Fisher & Paykel Healthcare Limited
 LivaNova PLC
 Gilead Sciences, Inc.
 Fresenius SE & Co. KGaA
 Besmed Health Business Corp.
 Armstrong Medical
 Smiths Medical (part of ICU Medical, Inc.)
 ResMed
 ALung Technologies, Inc.
 Medtronic
 F. Hoffmann-La Roche Ltd
 Hamilton Medical
 nice Neotech Medical Systems Pvt. Ltd.
 Pfizer Inc.
 WEINMANN Emergency Medical Technology GmbH + Co. KG
 NIPRO
 Terumo Medical Corporation
 Getinge AB
 EUROSETS

Methodology